Type(s) of colorectal cancer (CRC)-Adenocarcinoma of the colon Posts on Medivizor
Navigation Menu

Type(s) of colorectal cancer (CRC)-Adenocarcinoma of the colon Posts on Medivizor

Liver surgery is a safe treatment for patients with BRAF-positive colorectal cancer liver metastasis

Posted by on Jul 8, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the outcomes of patients with BRAF-positive colorectal cancer liver-metastasis (CRLM; spread to the liver) undergoing surgery. Researchers suggested that surgery is associated with improved outcomes for these patients. Some background Colorectal cancer is one of the most common cancers in the US. Around 25% of...

Read More

Looking for patients with inoperable metastatic colorectal cancer to test a new immunotherapy

Posted by on Jul 5, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1/2 trial is examining the effectiveness of a new immunotherapy in the treatment of patients with advanced colorectal cancer (CRC). The main outcome to be measured will be tumor response to the treatment. This study is being conducted in Texas, USA.   The details CRC is the third most common cancer worldwide. The 5-year...

Read More

Is chemotherapy immediately after colon cancer surgery safe and feasible?

Posted by on Jun 25, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the impact of starting chemotherapy treatment immediately after colon cancer surgery. Researchers suggested that this option is safe. Some background Colorectal cancer is the third most common cancer worldwide. The standard treatment is surgery and chemotherapy. However, colon cancer surgery is associated with a...

Read More

Tumor surgery improves survival of patients with stage 4 colorectal cancer

Posted by on Jun 23, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the outcomes of stage 4 colorectal cancer patients who received surgery. Researchers suggested that surgery in these patients is associated with an improved 5-year survival rate. Some background Colorectal cancer is the second leading cause of death in the US. A significant number of patients presents have stage 4...

Read More

Searching for patients with previously treated colorectal cancer to test this new immunotherapy option

Posted by on Jun 14, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1b trial is examining the effectiveness and safety of cibisatamab in combination with atezolizumab (Tecentriq) after treatment with obinutuzumab (Gazyva) in patients with previously treated metastatic colorectal carcinoma (mCRC).  The main outcomes to be measured will be side effects and...

Read More

Cetuximab improves the outcomes of previously untreated patients with metastatic colorectal cancer

Posted by on May 28, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of first-line treatment with cetuximab (Erbitux) and bevacizumab (Avastin) in advanced colorectal cancer. Researchers suggested that cetuximab is associated with better outcomes when compared to bevacizumab.    Some background Colorectal cancer is the third most common cancer worldwide....

Read More

Searching for patients with advanced colorectal cancer to test a new T-cell treatment

Posted by on May 26, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 2 trial will investigate the effectiveness of genetically-engineered cell treatment (GECT) in advanced cancer.  The main outcome will be the response to treatment. This trial is recruiting at the National Cancer Institute, Maryland, US.  The details There are limited treatment options for advanced cancer. One...

Read More

Searching for patients with colorectal cancer to test this new treatment combination

Posted by on May 19, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the safety and effectiveness of combination therapy with pembrolizumab (Keytruda) and lenvatinib (Lenvima) for advanced or unresponsive colorectal cancer (CRC) and other solid tumors.  The main outcome to be measured will be the objective response rate (ORR; the percentage of participants who have complete...

Read More

Looking for participants to test a new vaccine to treat advanced colorectal cancer

Posted by on Apr 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness and toxicity of PolyPEPI1018 vaccine in the treatment of advanced colorectal cancer. The main outcome to be measured is tumor response to the treatment. This trial will be conducted in Italy, and Minnesota, US. The details The standard treatment for metastatic (spread to other parts of the body)...

Read More

New treatment improves tumor response in patients with HER2 positive metastatic colorectal cancer

Posted by on Apr 8, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of pertuzumab (Perjeta) and trastuzumab (Herceptin) in patients with colorectal cancer and HER2 mutation (an abnormal gene). Researchers suggested that this treatment could be a safe option for patients with metastatic (spread to other parts of the body) colorectal cancer (mCRC). Some background...

Read More